Literature DB >> 22933862

Do statins reduce patients' risk of hepatocellular carcinoma?

.   

Abstract

Entities:  

Year:  2012        PMID： 22933862      PMCID： PMC3424426     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  13 in total

1.  Statin use and the risk of liver cancer: a population-based case–control study.

Authors:  Hui-Fen Chiu; Shu-Chen Ho; Chih-Cheng Chen; Chun-Yuh Yang
Journal:  Am J Gastroenterol       Date:  2010-12-14       Impact factor: 10.864

2.  Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.

Authors:  Yu-Tse Tsan; Chang-Hsing Lee; Jung-Der Wang; Pau-Chung Chen
Journal:  J Clin Oncol       Date:  2012-01-23       Impact factor: 44.544

3.  Statins and cancer risk: a meta-analysis.

Authors:  Krista M Dale; Craig I Coleman; Nickole N Henyan; Jeffrey Kluger; C Michael White
Journal:  JAMA       Date:  2006-01-04       Impact factor: 56.272

Review 4.  Regulation of the mevalonate pathway.

Authors:  J L Goldstein; M S Brown
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

5.  Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort.

Authors:  Eric J Jacobs; Christina C Newton; Michael J Thun; Susan M Gapstur
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

6.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

Review 7.  Statins and risk of cancer: a systematic review and metaanalysis.

Authors:  Danielle R L Browning; Richard M Martin
Journal:  Int J Cancer       Date:  2007-02-15       Impact factor: 7.396

8.  3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.

Authors:  Akio Horiguchi; Makoto Sumitomo; Junichi Asakuma; Takako Asano; Tomohiko Asano; Masamichi Hayakawa
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

9.  3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis.

Authors:  Toshiyuki Kusama; Mutsuko Mukai; Teruo Iwasaki; Masaharu Tatsuta; Yoshirou Matsumoto; Hitoshi Akedo; Masahiro Inoue; Hiroyuki Nakamura
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

10.  Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.

Authors:  Jim Dimitroulakos; Wilson H Marhin; Jason Tokunaga; Jonathan Irish; Patrick Gullane; Linda Z Penn; Suzanne Kamel-Reid
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.